Important Update: Shortage of Teva-Clobazam 10 mg Tablets
A shortage of the epilepsy medication Teva-Clobazam 10 mg tablets has recently gained media attention due to supply chain disruptions. According to a statement from Teva Canada, the backorder is linked to delays in receiving the active pharmaceutical ingredient (API) from a European supplier, with an expected return to market in April 2025. Numerous stories have highlighted the impact of this shortage, focusing on the experiences of Rebecca Roland and her father, John Dickinson. To read more about their story and see examples of the media coverage they have received, please click on the links below.
- CTV News: Some epilepsy patients worry their seizures will return amid medication shortage
- CTV National News: Epilepsy medication concerns
- CP24: Ontario family says drug-maker helped them find epilepsy medication amidst ongoing shortage
What You Can Do
If you or a loved one is affected by this shortage, we urge you to act quickly to secure continued access to your medication. Teva Canada recommends that patients consult with their healthcare provider to explore available treatment options during this period. Here’s what you can do:
- Check Your Supply: Regularly monitor your current supply of Teva-Clobazam 10 mg tablets.
- Talk to Your Healthcare Provider: Reach out to your doctor, pharmacist, or healthcare team to discuss possible alternatives or adjustments to your treatment plan.
- Create a Contingency Plan: Work with your healthcare provider to establish a plan of action in case you’re unable to access your medication.
- Let us know: We, along with our fellow Canadian Epilepsy Alliance agencies across the country will be tracking this issue, and the more people that we know it is affecting, the more pressure, we as a community, can put on Teva Canada to find a solution. Please write to us at [email protected] and cc [email protected].
Share Your Story
Your voice matters, and by sharing your story, you can help others understand the impact of this shortage on the epilepsy community and advocate for changes that could improve access to vital medications. If you are interested in sharing your experience with the Teva-Clobazam shortage, as Rebecca and John have done, we invite you to reach out to our Director of Communications, Mackenzie Muldoon, at [email protected].
For more information on drug shortages in Canada, you can visit Health Canada’s Drug Shortages Page.